Provided by Tiger Trade Technology Pte. Ltd.

Checkmate Pharmaceuticals

10.50
0.0000
Volume:- -
Turnover:668.00K
Market Cap:231.40M
PE:-3.60
High:10.50
Open:10.50
Low:10.50
Close:10.50
52wk High:10.50
52wk Low:2.00
Shares:22.04M
Float Shares:6.52M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9195
EPS(LYR):-2.8407
ROE:-75.44%
ROA:-42.31%
PB:4.21
PE(LYR):-3.70

Loading ...

Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 08, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 20, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 05, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 18, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Aug 19, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Aug 18, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 14, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Aug 11, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 04, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 04, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 03, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 03, 2020

Correspondence

CORRESP [Cover] - Correspondence